Understanding diabetes and heart disease in Africa

  • September 11, 2013
Understanding diabetes and heart disease in Africa

Observational studies are needed to understand the growing burden of cardiovascular disease and diabetes in sub-Saharan Africa, according to a study led by a Gates Cambridge Scholar.

Prospective observational studies are needed to understand the growing burden of cardiovascular disease and diabetes in sub-Saharan Africa, according to a study led by a Gates Cambridge Scholar.

The study, Cardiometabolic Risk in a Rural Ugandan Population, led by Georgina Murphy [2009], is published in the journal Diabetes Care.

It says that few studies of diabetes and cardiovascular disease have been carried out on African populations, leading to an incomplete understanding of their prevalence and distribution.

A better understanding, says the research, could lead to better preventive health policies.

The researchers involved over 8,000 participants living in rural areas of Uganda, all aged 13 and over. Fifty-five per cent were women. Participants were assessed for whether they were at risk of developing diabetes or cardiovascular disease using the Framingham Risk Score (FRS), a gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual, and metabolic syndrome, for which their are many definitions including the World Health Organization, the International Diabetes Federation, and the newly proposed harmonised definition.

The harmonised definition of metabolic syndrome appeared to be the most sensitive and showed a prevalence of 13.7%. The prevalence of metabolic syndrome increased with age and women had a higher prevalence, possibly linked to higher obesity in women.

However, according to the FRS, men had a higher risk of cardiovascular disease compared to women. The researchers say there were inconsistencies in results using the different measurements of risk and add that this shows the need for prospective observational studies (studies which follow people over time) in sub-Saharan Africa in order to better understand the relationship between such risk measurements and actual disease outcome.

Georgina, who is doing a PhD in Public Health and Primary Care, says: “Cardiometabolic diseases, such as heart disease and diabetes, are rapidly becoming leading causes of illness and death in sub-Saharan Africa. Current methods for identifying individuals who might be at increased risk of cardiometabolic diseases include diagnosing metabolic syndrome, for which there are many definitions, and calculating the Framingham risk score.However, the impact and relevance of such approaches to identify high risk population groups in sub-Saharan African populations is unclear. This study highlight the need for prospective observational studies in sub-Saharan African populations to evaluate and assess the distribution and determinants of cardiometabolic disease risk and to help to inform policy and healthcare programmes in sub-Saharan Africa.”

Picture credit: www.freedigitalphotos.net and jscreationzs

Latest News

Understanding how a city works

When he was a child, Ibrahim Abdou’s father would tell him nostalgic stories about Egypt. The family had moved to Riyadh, where Ibrahim was born, for his father’s work as a civil engineer, but travelled back to Egypt for long summer holidays. Ibrahim loved that time of year, seeing members of his extended family in […]

Scholar named one of Fortune magazine’s 40 under 40

A Gates Cambridge Scholar has been named one of Fortune Magazine’s 40 Under 40 for the year 2021. Kate Brandt, Chief Sustainability Officer at Google and the first Federal Chief Sustainability Office in the Obama administration, was listed in Fortune magazine’s prestigious annual list of people to watch out for. Brandt [2007], who did an […]

Developing sustainable SMEs

A Gates Cambridge Scholar will be moderating a panel on future-ready SMEs at the forthcoming World Economic Forum’s “Sustainable Development Impact Summit 2021” beginning on 20th September. Ariel de Fauconberg [2020], who is doing a PhD in Management Studies, will host the session, which previews a report she co-wrote on future-ready SMEs in collaboration with her […]

New in vitro model could predict foetal abnormalities more reliably

A new 3D model of embryonic stem cells called gastruloids could predict whether drugs may cause abnormalities in early embryos more reliably than other in vitro models, according to new research. The researchers, led by Gates Cambridge Scholar Veronika Mantziou [2019], have just published their findings in Reproductive Toxicology. Pharmaceuticals intended for pregnant women need […]